CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-1 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-1 trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new oral drug, seclidemstat, combined with an existing drug, azacitidine, for adults with certain advanced blood cancers (MDS and CMML) that have not responded well to prior treatment. The main goals are to find the safest and most effective dose of the ne…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested for patients with no other options
Disease control Recruiting nowThis is a first-in-human study testing a new drug called STX-0712 in patients with advanced forms of blood cancer (CMML and AML) who have no remaining standard treatment options. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the canc…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-1
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC